Home
/
BioCorRx Inc.
/
Financials
/
Quarterly
BioCorRx Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that BioCorRx Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$635.2K
Nov 14, 2025
Q2
2025
Jun 30, 2025
$178.2K
Aug 14, 2025
Q1
2024
Mar 31, 2025
$134.9K
May 15, 2025
Q3
2025
Sep 30, 2024
$0
Nov 14, 2025
Q2
2025
Jun 30, 2024
$4.0K
Aug 14, 2025
Q1
2024
Mar 31, 2024
$3.6K
May 15, 2025
Q3
2024
Sep 30, 2023
$10.1K
Nov 14, 2024
Q2
2024
Jun 30, 2023
$19.6K
Aug 13, 2024
Q1
2024
Mar 31, 2023
$40.4K
May 15, 2024
Q3
2023
Sep 30, 2022
$94.4K
Nov 14, 2023
Q2
2023
Jun 30, 2022
$16.0K
Aug 14, 2023
Q1
2023
Mar 31, 2022
$20.5K
May 15, 2023
Q3
2022
Sep 30, 2021
$8.8K
Nov 14, 2022
Q2
2022
Jun 30, 2021
$15.7K
Aug 15, 2022
Q1
2022
Mar 31, 2021
$10.1K
May 16, 2022
Q3
2021
Sep 30, 2020
$29.8K
Nov 15, 2021
Q2
2021
Jun 30, 2020
$33.7K
Aug 13, 2021
Q1
2021
Mar 31, 2020
$36.9K
May 17, 2021
Q3
2020
Sep 30, 2019
$46.6K
Nov 16, 2020
Q2
2020
Jun 30, 2019
$66.0K
Aug 14, 2020
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2018
Jun 30, 2018
$98.7K
Aug 14, 2018
Q1
2018
Mar 31, 2018
$147.7K
May 18, 2018
Q3
2017
Sep 30, 2017
$147.6K
Nov 14, 2017
Q2
2018
Jun 30, 2017
$210.5K
Aug 14, 2018
Q1
2018
Mar 31, 2017
$134.2K
May 18, 2018
Q3
2017
Sep 30, 2016
$167.6K
Nov 14, 2017
Q2
2017
Jun 30, 2016
$187.9K
Aug 11, 2017
Q1
2017
Mar 31, 2016
$230.4K
May 15, 2017
Q3
2016
Sep 30, 2015
$118.2K
Nov 17, 2016
Q2
2016
Jun 30, 2015
$457.8K
Aug 17, 2016
Q1
2016
Mar 31, 2015
$275.5K
May 23, 2016
Q3
2015
Sep 30, 2014
$434.0K
Nov 16, 2015
Q2
2015
Jun 30, 2014
$238.0K
Aug 12, 2015
Q1
2015
Mar 31, 2014
$130.8K
May 15, 2015
Q3
2014
Sep 30, 2013
$277.4K
Nov 10, 2014
Q2
2014
Jun 30, 2013
$500.0K
Aug 14, 2014
Q1
2014
Mar 31, 2013
$387.2K
May 14, 2014
Q3
2013
Sep 30, 2012
$64.0K
Nov 14, 2013
Q2
2013
Jun 30, 2012
$179.2K
Aug 19, 2013
Q1
2013
Mar 31, 2012
$260.9K
May 15, 2013
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($1.92M)
Nov 14, 2025
Q2
2025
Jun 30, 2025
($1.23M)
Aug 14, 2025
Q1
2024
Mar 31, 2025
($841.4K)
May 15, 2025
Q3
2025
Sep 30, 2024
($1.49M)
Nov 14, 2025
Q3
2024
Jun 30, 2024
($1.23M)
Nov 14, 2024
Q2
2025
Jun 30, 2024
($1.22M)
Aug 14, 2025
Q2
2024
Mar 31, 2024
($1.24M)
Aug 13, 2024
Q3
2024
Mar 31, 2024
($1.24M)
Nov 14, 2024
Q1
2024
Mar 31, 2024
($1.24M)
May 15, 2025
Q3
2024
Sep 30, 2023
($867.3K)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($923.5K)
Aug 13, 2024
Q3
2024
Jun 30, 2023
($923.5K)
Nov 14, 2024
Q2
2024
Mar 31, 2023
($1.01M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($1.01M)
May 15, 2024
Q3
2024
Mar 31, 2023
($1.01M)
Nov 14, 2024
Q3
2023
Sep 30, 2022
($951.0K)
Nov 14, 2023
Q2
2023
Jun 30, 2022
($1.32M)
Aug 14, 2023
Q3
2023
Jun 30, 2022
($1.32M)
Nov 14, 2023
Q2
2023
Mar 31, 2022
($945.0K)
Aug 14, 2023
Q3
2023
Mar 31, 2022
($945.0K)
Nov 14, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($1.95M)
Nov 14, 2025
Q2
2025
Jun 30, 2025
($1.41M)
Aug 14, 2025
Q1
2024
Mar 31, 2025
($937.9K)
May 15, 2025
Q3
2025
Sep 30, 2024
($1.66M)
Nov 14, 2025
Q2
2025
Jun 30, 2024
($1.37M)
Aug 14, 2025
Q1
2024
Mar 31, 2024
($968.7K)
May 15, 2025
Q3
2024
Sep 30, 2023
($961.9K)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($946.9K)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($1.06M)
May 15, 2024
Q3
2023
Sep 30, 2022
($1.03M)
Nov 14, 2023
Q2
2023
Jun 30, 2022
($1.36M)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($1.12M)
May 15, 2023
Q3
2022
Sep 30, 2021
($1.63M)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($963.4K)
Aug 15, 2022
Q1
2022
Mar 31, 2021
($1.58M)
May 16, 2022
Q3
2021
Sep 30, 2020
($2.05M)
Nov 15, 2021
Q2
2021
Jun 30, 2020
($2.15M)
Aug 13, 2021
Q1
2021
Mar 31, 2020
($1.52M)
May 17, 2021
Q3
2020
Sep 30, 2019
($885.6K)
Nov 16, 2020
Q2
2020
Jun 30, 2019
($1.60M)
Aug 14, 2020